Correction of Fanconi Anemia Mutation Using the Crispr/Cas9 System

被引：0
|
作者：
Kawashima, Nozomu [1 ]
Okuno, Yusuke [1 ]
Sekiya, Yuko [1 ]
Wang, Xinan [1 ]
Narita, Atsushi [1 ]
Doisaki, Sayoko [1 ]
Kamei, Michi [1 ]
Nishio, Nobuhiro [1 ]
Muramatsu, Hideki [1 ]
Hama, Asahito [1 ]
Takahashi, Yoshiyuki [1 ]
Kojima, Seiji [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] What is CRISPR/Cas9?
    Redman, Melody
    King, Andrew
    Watson, Caroline
    King, David
    ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 2016, 101 (04): : 213 - 215
  • [42] CRISPR/CAS9 Technologies
    Williams, Bart O.
    Warman, Matthew L.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (05) : 883 - 888
  • [43] Correction of the Dystrophin Gene By the CRISPR/Cas9 System in a Mouse Model of Muscular Dystrophy
    Nelson, Christopher E.
    Ousterout, David G.
    Robinson-Hamm, Jacqueline N.
    Moreb, Eirik A.
    Castellanos, Ruth M.
    Ran, Fei Ann
    Yan, Winston
    Zhang, Feng
    Asokan, Aravind
    Gersbach, Charles A.
    MOLECULAR THERAPY, 2015, 23 : S157 - S158
  • [44] Advances in CRISPR/Cas9
    Zhu, Youmin
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [45] Correction of the exon 2 duplication in DMD myoblasts by a single CRISPR/Cas9 system
    Lattanzi, A.
    Duguez, S.
    Moiani, A.
    Izmiryan, A.
    Barbon, E.
    Martin, S.
    Mamchaoui, K.
    Mouly, V.
    Bernardi, F.
    Mavilio, F.
    Bovolenta, M.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S187 - S187
  • [46] Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System
    Lattanzi, Annalisa
    Duguez, Stephanie
    Moiani, Arianna
    Izmiryan, Araksya
    Barbon, Elena
    Martin, Samia
    Mamchaoui, Kamel
    Mouly, Vincent
    Bernardi, Francesco
    Mavilio, Fulvio
    Bovolenta, Matteo
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 11 - 19
  • [47] Correction: Corrigendum: In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
    Danilo Maddalo
    Eusebio Manchado
    Carla P. Concepcion
    Ciro Bonetti
    Joana A. Vidigal
    Yoon-Chi Han
    Paul Ogrodowski
    Alessandra Crippa
    Natasha Rekhtman
    Elisa de Stanchina
    Scott W. Lowe
    Andrea Ventura
    Nature, 2015, 524 : 502 - 502
  • [48] Nanotechnology and CRISPR/Cas9 system for sustainable agriculture
    Kanika Khanna
    Puja Ohri
    Renu Bhardwaj
    Environmental Science and Pollution Research, 2023, 30 : 118049 - 118064
  • [49] Application of the CRISPR/Cas9 system in Dioscorea zingiberensis
    Shan Feng
    Wei Song
    Ruirui Fu
    Hong Zhang
    Anran Xu
    Jiaru Li
    Plant Cell, Tissue and Organ Culture (PCTOC), 2018, 135 : 133 - 141
  • [50] The CRISPR/Cas9 System Delivered by Extracellular Vesicles
    Zhu, Xinglong
    Gao, Mengyu
    Yang, Yongfeng
    Li, Weimin
    Bao, Ji
    Li, Yi
    PHARMACEUTICS, 2023, 15 (03)
12345